82_FR_52066 82 FR 51851 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

82 FR 51851 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 215 (November 8, 2017)

Page Range51851-51852
FR Document2017-24267

Federal Register, Volume 82 Issue 215 (Wednesday, November 8, 2017) 
[Federal Register Volume 82, Number 215 (Wednesday, November 8, 2017)]
[Notices]
[Pages 51851-51852]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-24267]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity 
Research.
    Date: November 27, 2017
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542 (301) 
594-8898, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK P01-A1 Review.
    Date: December 1, 2017.
    Time: 9:50 a.m. to 11:50 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301) 
594-4719, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK RC2 Review.
    Date: December 5, 2017.
    Time: 10:00 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).

[[Page 51852]]

    Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301) 
594-4719, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Personalized Biofeedback 
to Enhance Performance Training in Elite Athletes Using Exhaled 
Breath 13CO2/12CO2 as a Metabolic Marker.
    Date: December 11, 2017.
    Time: 1:00 p.m. to 2:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301) 
594-8895, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK SBIR Phase II 
Exploratory Clinical Trials.
    Date: December 15, 2017.
    Time: 10:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Thomas A. Tatham, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301) 
594-3993, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: November 2, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-24267 Filed 11-7-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51851 Contact Person: Chee Lim, Ph.D., Center Vascular Diseases Research; 93.838, Lung DEPARTMENT OF HEALTH AND for Scientific Review, National Institutes of Diseases Research; 93.839, Blood Diseases HUMAN SERVICES Health, 6701 Rockledge Drive Room 4128, and Resources Research, National Institutes Bethesda, MD 20892, 301–435–1850, limc4@ of Health, HHS) National Institutes of Health csr.nih.gov. Dated: November 2, 2017. (Catalogue of Federal Domestic Assistance National Institute of Diabetes and Program Nos. 93.306, Comparative Medicine; Michelle Trout, Digestive and Kidney Diseases; Notice 93.333, Clinical Research, 93.306, 93.333, Program Analyst, Office of Federal Advisory of Closed Meetings 93.337, 93.393–93.396, 93.837–93.844, Committee Policy. 93.846–93.878, 93.892, 93.893, National [FR Doc. 2017–24265 Filed 11–7–17; 8:45 am] Pursuant to section 10(d) of the Institutes of Health, HHS) Federal Advisory Committee Act, as BILLING CODE 4140–01–P Dated: November 2, 2017. amended, notice is hereby given of the David Clary, following meetings. The meetings will be closed to the Program Analyst, Office of Federal Advisory DEPARTMENT OF HEALTH AND public in accordance with the Committee Policy. HUMAN SERVICES provisions set forth in sections [FR Doc. 2017–24262 Filed 11–7–17; 8:45 am] National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., BILLING CODE 4140–01–P as amended. The grant applications and National Heart, Lung, and Blood the discussions could disclose Institute: Notice of Closed Meeting confidential trade secrets or commercial DEPARTMENT OF HEALTH AND property such as patentable material, HUMAN SERVICES Pursuant to section 10(d) of the and personal information concerning National Institutes of Health Federal Advisory Committee Act, as individuals associated with the grant amended, notice is hereby given of a applications, the disclosure of which National Heart, Lung, and Blood meeting of the NHLBI Special Emphasis would constitute a clearly unwarranted Institute; Notice of Meeting Panel. invasion of personal privacy. Pursuant to section 10(a) of the The meeting will be closed to the Name of Committee: National Institute of Federal Advisory Committee Act, as public in accordance with the Diabetes and Digestive and Kidney Diseases provisions set forth in sections Special Emphasis Panel; Time-Sensitive amended, notice is hereby given of a Obesity Research. meeting of the National Asthma 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: November 27, 2017 Education Prevention Program as amended. The grant applications and Time: 10:00 a.m. to 12:00 p.m. Coordinating Committee. the discussions could disclose Agenda: To review and evaluate grant The meeting will be open to the confidential trade secrets or commercial applications. public, with attendance limited to space property such as patentable material, Place: National Institutes of Health, Two available. Individuals who plan to and personal information concerning Democracy Plaza, 6707 Democracy attend and need special assistance, such individuals associated with the grant Boulevard, Bethesda, MD 20892 (Telephone as sign language interpretation or other applications, the disclosure of which Conference Call). reasonable accommodations, should would constitute a clearly unwarranted Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, Review Branch, notify the Contact Person listed below invasion of personal privacy. DEA, NIDDK, National Institutes of Health, in advance of the meeting. Name of Committee: National Heart, Lung, Room 7353, 6707 Democracy Boulevard, Name of Committee: National Asthma and Blood Institute Special Emphasis Panel; Bethesda, MD 20892–2542 (301) 594–8898, Education Prevention Program Coordinating NHLBI TOPMed Data Analysis. barnardm@extra.niddk.nih.gov. Committee. Date: December 1, 2017. Name of Committee: National Institute of Date: December 14, 2017. Time: 8:00 a.m. to 5:00 p.m. Diabetes and Digestive and Kidney Diseases Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant Special Emphasis Panel; NIDDK P01–A1 Agenda: Welcome and committee charge. Review. applications. Place: National Institutes of Health, 6701 Date: December 1, 2017. Rockledge Drive, Suite 10018, Bethesda, MD Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Time: 9:50 a.m. to 11:50 a.m. 20892 (Virtual Meeting-Webinar). Agenda: To review and evaluate grant Contact Person: James P. Kiley, Ph.D., Washington, DC 20015. applications. Director, Division of Lung Diseases, National Contact Person: Susan Wohler Sunnarborg, Place: National Institutes of Health, Two Heart, Lung, and Blood Institute, National Ph.D., Scientific Review Officer, Office of Democracy Plaza, 6707 Democracy Institutes of Health, 6701 Rockledge Drive, Scientific Review/DERA, National, Heart, Boulevard, Bethesda, MD 20892 (Telephone Suite 10018, Bethesda, MD 20892–7952, 301– Lung, and Blood Institute, 6701 Rockledge Conference Call). 435–0233, kileyj@nhlbi.nih.gov. Drive, Room 7182, Bethesda, MD 20892, Contact Person: Xiaodu Guo, MD, Ph.D., Any interested person may file written (301) 827–7987, susan.sunnarborg@nih.gov. Scientific Review Officer, Review Branch, comments with the committee by forwarding (Catalogue of Federal Domestic Assistance DEA, NIDDK, National Institutes of Health, the statement to the Contact Person listed on Program Nos. 93.233, National Center for Room 7023, 6707 Democracy Boulevard, this notice. The statement should include the Sleep Disorders Research; 93.837, Heart and Bethesda, MD 20892–5452 (301) 594–4719, name, address, telephone number and when Vascular Diseases Research; 93.838, Lung guox@extra.niddk.nih.gov. applicable, the business or professional Name of Committee: National Institute of Diseases Research; 93.839, Blood Diseases affiliation of the interested person. Diabetes and Digestive and Kidney Diseases and Resources Research, National Institutes Information is also available on the Special Emphasis Panel; NIDDK RC2 Review. of Health, HHS) ethrower on DSK3G9T082PROD with NOTICES Institute’s/Center’s home page: http:// Date: December 5, 2017. www.nhlbi.nih.gov/health-pro/resources/ Dated: November 2, 2017. Time: 10:00 a.m. to 11:30 a.m. lung/naci/asthma-info/naepp.htm, where an Michelle Trout, Agenda: To review and evaluate grant agenda and any additional information for applications. the meeting will be posted when available. Program Analyst, Office of Federal Advisory Place: National Institutes of Health, Two Committee Policy. (Catalogue of Federal Domestic Assistance Democracy Plaza, 6707 Democracy Program Nos. 93.233, National Center for [FR Doc. 2017–24266 Filed 11–7–17; 8:45 am] Boulevard, Bethesda, MD 20892 (Telephone Sleep Disorders Research; 93.837, Heart and BILLING CODE 4140–01–P Conference Call). VerDate Sep<11>2014 17:26 Nov 07, 2017 Jkt 244001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1

51852 Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices Contact Person: Xiaodu Guo, MD, Ph.D., published in the Federal Register on establishes the requirement for Scientific Review Officer, Review Branch, October 18, 2017, 82 FR 48522–48523. importers of record to make entry for DEA, NIDDK, National Institutes of Health, The meeting will be held on merchandise to be imported into the Room 7023, 6707 Democracy Boulevard, November 7, 2017. The meeting time customs territory of the United States. Bethesda, MD 20892–5452 (301) 594–4719, guox@extra.niddk.nih.gov. and location remain the same. The Customs entry information is used by Name of Committee: National Institute of meeting is closed to the public. U.S. Customs and Border Protection Diabetes and Digestive and Kidney Diseases Dated: November 2, 2017. (CBP) and Partner Government Agencies Special Emphasis Panel; Personalized (PGAs) to determine whether Melanie J. Pantoja, Biofeedback to Enhance Performance merchandise may be released from CBP Program Analyst, Office of Federal Advisory Training in Elite Athletes Using Exhaled custody. Importers of record are also Committee Policy. Breath 13CO2/12CO2 as a Metabolic Marker. obligated to complete the entry by filing Date: December 11, 2017. [FR Doc. 2017–24264 Filed 11–7–17; 8:45 am] an entry summary declaring the value, Time: 1:00 p.m. to 2:15 p.m. BILLING CODE 4140–01–P classification and rate of duty applicable Agenda: To review and evaluate grant applications. to the merchandise and such other Place: National Institutes of Health, Two information as is necessary for CBP to Democracy Plaza, 6707 Democracy DEPARTMENT OF HOMELAND properly assess duties, collect accurate Boulevard, Bethesda, MD 20892 (Telephone SECURITY statistics and determine whether any Conference Call). other applicable requirement of law is Contact Person: Paul A. Rushing, Ph.D., U.S. Customs and Border Protection met. See 19 U.S.C. 1484(a)(1)(B). Scientific Review Officer, Review Branch, Section 505 of the Tariff Act of 1930, DEA, NIDDK, National Institutes of Health, Automated Commercial Environment as amended (19 U.S.C. 1505), Room 7345, 6707 Democracy Boulevard, (ACE) Becoming the Sole CBP- establishes the requirement for Bethesda, MD 20892–5452 (301) 594–8895, Authorized Electronic Data importers of record to deposit with CBP rushingp@extra.niddk.nih.gov. Interchange (EDI) System for the amount of duties and fees estimated Name of Committee: National Institute of Generating, Transmitting and Updating to be payable on merchandise unless Diabetes and Digestive and Kidney Diseases Daily and Monthly Statements Special Emphasis Panel; NIDDK SBIR Phase that merchandise is entered for II Exploratory Clinical Trials. AGENCY: U.S. Customs and Border warehouse or transportation, or under Date: December 15, 2017. Protection, Department of Homeland bond. According to section 141.101 of Time: 10:00 a.m. to 12:30 p.m. Security. Title 19 of the Code of Federal Agenda: To review and evaluate grant ACTION: General notice. Regulations (CFR), estimated duties applications. shall either be deposited with a CBP Place: National Institutes of Health, Two SUMMARY: This document announces officer at the time of filing of entry or Democracy Plaza, 6707 Democracy entry summary documentation, or be Boulevard, Bethesda, MD 20892 (Telephone that the Automated Commercial Conference Call). Environment (ACE) will be the sole transmitted to CBP pursuant to the Contact Person: Thomas A. Tatham, Ph.D., electronic data interchange (EDI) system statement processing method. Scientific Review Officer, Review Branch, authorized by U.S. Customs and Border A. Statement Processing DEA, NIDDK, National Institutes of Health, Protection (CBP) for generating, Room 7021, 6707 Democracy Boulevard, transmitting, and updating daily and Statement processing is a voluntary Bethesda, MD 20892–5452 (301) 594–3993, monthly statements for all entries automated program for participants in tathamt@mail.nih.gov. except reconciliation (type 09) entries. the Automated Broker Interface (ABI) (Catalogue of Federal Domestic Assistance This document also announces that the which allows entries to be grouped on Program Nos. 93.847, Diabetes, Automated Commercial System (ACS) a daily basis by importer or filer, and Endocrinology and Metabolic Research; allows payment of related duties, fees 93.848, Digestive Diseases and Nutrition will no longer be a CBP-authorized EDI system for processing such statements. and taxes by a single payment. See 19 Research; 93.849, Kidney Diseases, Urology CFR 24.1(a)(8) and 24.25 and 143.32(p). and Hematology Research, National Institutes DATES: As of December 9, 2017, ACE of Health, HHS) The preferred method of payment for will be the sole CBP-authorized EDI users of statement processing is by Dated: November 2, 2017. system for generating, transmitting, and Automated Clearinghouse (ACH). See 19 David Clary, updating daily and monthly statements, CFR 24.25(a). According to 19 CFR Program Analyst, Office of Federal Advisory and ACS will no longer be a CBP- 143.32(p), ACS, or any other CBP- Committee Policy. authorized EDI system for such purpose. authorized EDI system, generates the [FR Doc. 2017–24267 Filed 11–7–17; 8:45 am] FOR FURTHER INFORMATION CONTACT: For statement, which is transmitted BILLING CODE 4140–01–P policy-related questions, contact Randy electronically to the filer, consisting of Mitchell, Commercial Operations, a list of entry summaries and the Revenue and Entry, Trade Policy and amount of duties, fees and taxes due for DEPARTMENT OF HEALTH AND Programs, Office of Trade, via email at payment. Currently, the daily HUMAN SERVICES otentrysummary@cbp.dhs.gov. For statements are generated, transmitted technical questions, contact Celestine and updated in ACS. National Institutes of Health Harrell, Revenue Modernization Branch, Trade Transformation Office, Office of B. Periodic Monthly Statement Test Center for Scientific Review: Amended Trade, via email at Celestine.Harrell@ Program Notice of Meeting cbp.dhs.gov with a subject line As an alternative to paying ACH ethrower on DSK3G9T082PROD with NOTICES Notice is hereby given of a change in identifier reading ‘‘Statement Processing statements on a daily basis, participants the meeting of the Center for Scientific in ACE’’. in the periodic monthly statements Review Special Emphasis Panel, SUPPLEMENTARY INFORMATION: (PMS) test may pay ACH statements on November 8, 2017, 2:00 p.m. to a monthly basis. CBP announced its November 8, 2017, 4:00 p.m., National I. Background plan to conduct the PMS test on Institutes of Health, 6701 Rockledge Section 484 of the Tariff Act of 1930, February 4, 2004 in a notice in the Drive, Bethesda, MD, 20892 which was as amended (19 U.S.C. 1484), Federal Register (69 FR 5362) which VerDate Sep<11>2014 17:26 Nov 07, 2017 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1


Document Created: 2017-11-08 01:20:38
Document Modified: 2017-11-08 01:20:38
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 27, 2017
FR Citation82 FR 51851 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR